SIGN IN
Market Access Insights Manager jobs in United States
cer-icon
Apply on Employer Site
company-logo

Novo Nordisk · 12 hours ago

Market Access Insights Manager

Novo Nordisk is a company dedicated to creating lasting change for long-term health. The Market Access Insights Manager role focuses on providing customer insights to optimize market access strategies, collaborating with key stakeholders to inform strategic decisions based on data analysis.
BiotechnologyHealthcarePharmaceuticalHealth CareMedical
check
Growth Opportunities
check
H1B Sponsor Likelynote

Responsibilities

Collaborate with Managed Markets Sales, Market Access Leadership Teams, and the Associate Director, Insights & Analytics, Market Access to identify market and customer scenarios expected to have a high impact on NNI business:
Contributes to proactive advanced data analysis for identification of unexploited areas of opportunity to execute on NNI strategy
Co-develops business cases with concise and complete story-lines to communicate and secure buy-in on recommendations
Integrate relevant unstructured and structured data to support the development of analytical models
Develops analytical models to help make business critical decisions
Scan the market to understand key trends impacting markets and organized customers
Analysis of longitudinal claims and/or patient data, to e.g. identify Rx claims outcomes, patient out-of-pocket burden, etc
Provide analytical deep dives to Market Access Strategy, Channels, and Account teams

Qualification

Advanced analytical skillsStatistical modelingExperience in TableauAnalyzing pharmaceutical dataQuantitative analysis skillsProject management skillsIntellectual curiosityTeam communication skillsMicrosoft ExcelMicrosoft PowerPointCreative problem-solving

Required

A Bachelors degree from an accredited institution is required
Advanced analytical skills required
Analytical and/or technical proficiency at analyzing large data sets to derive insights required
Ability to lead without authority/reporting relationship required
Strong Microsoft Excel and PowerPoint skills required

Preferred

Finance, Business, Statistics, Economics, Engineering or related qualitative field preferred
Advanced degree in business analysis, data science, statistics, mathematics or any other analytical field is preferred
Statistical modeling preferred
Experience in Tableau is preferred
A minimum of 4 years analytics or analytics and research experience preferred
Experience analyzing pharmaceutical data, specifically Xponent, Xponent PlanTrak, and Patient-level data (e.g., LAAD or Symphony Health patient data) is preferred
Experience with data visualization tools preferred
Creative problem-solving with ability to solve complex unstructured problems; see opportunities through
Innate intellectual curiosity, demonstrated desire to take initiative, and ability to think creatively to solve
Outstanding team- and client-facing communication skills
Comfort operating in a fast-paced, environment, with a quality control focus and a documentation orientation
Project management skills
Quantitative analysis skills
Strong ability to work independently as well as in teams

Benefits

Medical, dental and vision coverage
Life insurance
Disability insurance
401(k) savings plan
Flexible spending accounts
Employee assistance program
Tuition reimbursement program
Group legal
Critical illness
Identity theft protection
Pet insurance
Auto/home insurance
Sick time policy
Flex-able vacation policy
Parental leave policy

Company

Novo Nordisk

company-logo
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.

H1B Sponsorship

Novo Nordisk has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (25)
2024 (21)
2023 (13)
2022 (10)
2021 (9)
2020 (12)

Funding

Current Stage
Public Company
Total Funding
$22M
2018-12-05Post Ipo Equity· $22M
1981-07-09IPO

Leadership Team

leader-logo
Lars Fruergaard Jørgensen
President and CEO
linkedin
leader-logo
Lars Sorensen
President & CEO
Company data provided by crunchbase